Statistical analysis
Development indicators from each participating country were obtained
from the World Bank Open Data platform6. Data on
COVID-19 incidence and mortality beginning on February 28, 2020 (first
COVID-19 case diagnosed in LATAM) to April 30, 2021 (day the last survey
closed) was extracted from the data repository for the 2019 Novel
Coronavirus Visual Dashboard operated by the Johns Hopkins University
Center for Systems Science and Engineering (JHU
CSSE).14
Respondent characteristics were reported using descriptive statistics.
Categorical variables were assessed by chi-square test. Univariate and
multivariable logistic analysis was done for the following health care
factors: treatment of new patients, treatment of active/ongoing cases,
suspension of outpatient procedures, suspension of oncologic surgeries,
suspension of radiation therapy sessions, suspension of stem cell
transplant (SCT) and suspension of surveillance consultations. We
calculated crude odds ratios and variables associated with significant
impact in a multivariable logistic regression analysis.
Radiation therapy sessions and SCT proportions were calculated based on
the total number of participants that reported having access to
radiation therapy or SCT. Participants who reported no access to those
services or answered ”Do not know” were excluded. Significance was
established when p values were less than 0.05. Statistical analyses were
performed using RStudio version 1.2.1335.